ARAC’s GFN Fives VIDEO is LIVE!  Global Forum on Nicotine Advocating THR: The Role of Nurses in Health Communication In this GFN Fives video,  Dr. Jessica Zdinak  sits down with Clinical Research Nurses  Elizabeth DeMartini , BSN, RN, and  Amanda Cox , BSN, RN, to explore the unique and powerful role nurses play in advancing tobacco harm reduction (THR). They share why empathy, trust, and truth are vital tools in helping people QUIT smoking. Drawing on their backgrounds in IC

Working Together > Working Alone: Reflections from the 2025  VCCRN | Virginia Coordinated Clinical Research Network  SUMMIT. Huge thank you to the organizers, especially  Lara D'Antonio  and the entire VCCRN team, for creating such a thoughtful and action-oriented event. The work is just getting started and ARAC looks forward to getting more involved with this evolving network! The opportunities to contribute, collaborate, and help build something lasting are right here.  Our

7th Annual  Next Generation Nicotine Delivery  USA Conference Harm Reduction PANEL: Key Developments Globally MODERATOR:  Willie McKinney Ph.D., DABT PANELISTS: Dr. Jessica Zdinak , Sarah Marking , Marina Murphy , Tobias Baude , Joseph Smith 🎥 SCROLL DOWN TO WATCH REPLAY This panel discussion focused on global harm reduction strategies related to nicotine and tobacco products, highlighting key markets, regulatory challenges, and cultural considerations. The discussion emphas

7th Annual Next Generation Nicotine Delivery USA Conference KEYNOTE | PMTA Module 5 & 6 Regulatory Expectations & Business Objectives Dr. Jessica Zdinak, our CEO and Chief Research Officer, gave a keynote presentation focused on bridging the gap between product development and market success in the tobacco and nicotine industry, particularly in light of regulatory expectations and consumer behavior. Zdinak emphasized the importance of understanding consumer needs and market d

7th Annual  Next Generation Nicotine Delivery  USA Conference "Beyond the Agency: From Oversight to Insight" PANEL HIGHLIGHTS MODERATOR:  Willie McKinney Ph.D., DABT PANELISTS: •  Roxana Weil, PhD, DABT •  Angela Ho-Chen •  Melis Coraggio •  Gabriel Muniz •  David Oliveira This panel featured former FDA/CTP employees who now operate within the industry or consulting sectors, offering insights on improving the relationship between the FDA and stakeholders. KEY TAKEAWAYS regard

SELLING FLAVORED NICOTINE PRODUCTS IN CALIFORNIA? California’s flavored tobacco restrictions continue to evolve — and the latest requirement is one every manufacturer should be preparing for NOW. ⏰ The clock is ticking. If your products will remain in the California market, now is the time to build the evidence you’ll need to support compliance — and to avoid steep penalties ahead.

ARAC is thrilled to attend the 2025 Virginia Coordinated Clinical Research Network Summit, hosted by the  Virginia Hospital & Healthcare Association (VHHA) !  Amanda Cox , Clinical Research Nurse, aims to forge powerful partnerships with clinical researchers, healthcare institutions, and life science industry leaders.  At ARAC, we focus on helping the 28.3 million people who smoke in the United States and 1.1 billion global smokers to STOP smoking combustible cigarettes. As t

The 7th  Next Generation Nicotine Delivery  Conference is due to take place June 4-5 2025 in Downtown Miami. ARAC is a proud SPONSOR & SPEAKER and will join 15+ EXHIBITORS & >150 ATTENDEES. This is the THIRD year ARAC has been active participants in this conference, gaining KEY insights from regulators, scientists, businesses, friends, and current and future clients. Come JOIN US! 📍Location: Miami, Florida 📆 Dates: June 4-5 | Hyatt Regency Miami REGISTER HERE:  https://lnkd

Grateful to  Global Action to End Smoking (GA)  for the kind invitation to last week’s exclusive gathering in New York City. Liz enjoyed joining the conversation on how we can better support people who want to quit smoking — and to contribute insights on the importance of tobacco harm reduction. One highlight of the event was Global Action’s announcement of a new grant to Northwell Health, aimed at advancing tobacco harm reduction in clinical settings. This work will help del

In recent years, several U.S. states have ramped up their efforts to regulate tobacco and nicotine products, with a particular focus on flavored ENDS products. These initiatives are typically designed to reduce the use and appeal of nicotine and tobacco products to youth. However, emerging research suggests that such bans may inadvertently harm adult smokers who rely on - or merely prefer flavored alternatives to help them reduce and quit smoking traditional cigarettes.  In r

Grateful to  Global Action to End Smoking (GA)  for the kind invitation to last week’s exclusive gathering in New York City. Liz enjoyed joining the conversation on how we can better support people who want to quit smoking — and to contribute insights on the importance of tobacco harm reduction. One highlight of the event was Global Action’s announcement of a new grant to Northwell Health, aimed at advancing tobacco harm reduction in clinical settings. This work will help del

Join  Applied Research and Analysis Company (ARAC)  THIS WEEK at  Food and Drug Law Institute (FDLI) !  📍Location: Washington, D.C. 📆 Dates & Location: May 15-16, Ronald Reagan Building and International Trade Center Our Lead Statistician,  Ian Jones, Ph.D. , will join the PANEL discussion "A Hint of Harm or Harm Reduction: Exploring the Role of Flavors in Evidence-Based Policy Making”. Moderated by  Rachael Schmidt  with fellow PANELISTS:  Dave Dobbins  &  Tony Abboud KEY